NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Tuesday that its second quarter revenues grew 11 percent year over year led by new product sales, particularly of its Sofia immunoassays.

Revenues for the three months ended June 30 increased to $34.9 million from $31.5 million in Q2 2014, above the average analysts' estimate of $34.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.